Stagliano, recently served as the CEO and co-founder of CytomX Therapeutics, will succeed interim CEO Peter Van Vlasselear.
Earlier, she worked as the COO of CytomX, which launched CytomX Therapeutics as well as Cynvenio Biosystems.
Prior to that Stagliano served for eight years at Millennium Pharmaceuticals and consulted to several local startups.